Gilead Sciences Inc's Covid-19 treatment remdesivir has no substantial effect on a patient's chances of survival, a c ...
Gilead Sciences Inc said Thursday a trial published in the New England Journal of Medicine showed its Covid-19 treatm ...
Johnson & Johnson on Thursday said the European Commission has approved an agreement which will see subsidiary Jansse ...
Regeneron Pharmaceuticals Inc said Thursday it has submitted a request for its Covid-19 vaccine, REGN-COV2, to the US ...
The European Commission says it has sealed a deal with pharmaceutical company Gilead Sciences Inc to buy 500,000 trea ...
US pharmaceutical giant Gilead Sciences Inc confirmed Sunday that it is buying American biotech firm Immunomedics, wh ...
Gilead Sciences Inc late Friday said its Remdesivir antiviral medication secured an emergency use authorisation from ...
Gilead Sciences Inc said Monday it has agreed to expand its oncology collaboration with Tango Therapeutics. Gilead w ...
Gilead Sciences Inc on Tuesday said it has received regulatory approval from the China National Medical Products Admi ...
Gilead Sciences Inc on Monday said it has submitted a new drug application to the US Food & Drug Administration for V ...
Gilead Sciences Inc on Thursday reported a loss in the second quarter as significantly higher costs added to falling ...
The European Commission has ordered 30,000 treatment doses of the antiviral medication remdesivir from US drugs giant ...
Gilead Sciences Inc on Tuesday said it will invest USD300 million to acquire a 49.9% stake in Tizona Therapeutics In ...
Gilead Sciences Inc on Friday announced additional data on Remdesivir as a possible treatment for Covid-19 which foun ...
Gilead Sciences Inc said on Friday the European Commission has granted conditional marketing authorisation for Veklur ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.